D Marson
Overview
Explore the profile of D Marson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Vellas B, Bateman R, Blennow K, Frisoni G, Johnson K, Katz R, et al.
J Prev Alzheimers Dis
. 2015 Aug;
2(2):128-135.
PMID: 26247004
For Alzheimer's disease treatment trials that focus on the pre-dementia stage of disease, outcome measures are needed that will enable assessment of disease progression in patients who are clinically normal....
3.
Marson D, Laurini E, Posocco P, Fermeglia M, Pricl S
Nanoscale
. 2014 Oct;
7(9):3876-87.
PMID: 25340619
Generation 2 cationic carbosilane dendrimers hold great promise as internalizing agents for gene therapy as they present low toxicity and retain and internalize the genetic material as an oligonucleotide or...
4.
Brune S, Schepmann D, Klempnauer K, Marson D, Dal Col V, Laurini E, et al.
Biochemistry
. 2014 Apr;
53(18):2993-3003.
PMID: 24766040
The σ1 receptor is an integral membrane protein that shares no homology with other receptor systems, has no unequivocally identified natural ligands, but appears to play critical roles in a...
5.
Clark D, Wadley V, Kapur P, DeRamus T, Singletary B, Nicholas A, et al.
Neuropsychologia
. 2014 Jan;
54:98-111.
PMID: 24384308
Objective: To evaluate assumptions regarding semantic (noun), verb, and letter fluency in mild cognitive impairment (MCI) and Alzheimer disease (AD) using novel techniques for measuring word similarity in fluency lists...
6.
Posocco P, Laurini E, Dal Col V, Marson D, Karatasos K, Fermeglia M, et al.
Curr Med Chem
. 2012 Sep;
19(29):5062-87.
PMID: 22963635
Due to the relative easy synthesis and commercial availability, nanovectors based on dendrimers and dendrons are among the most utilized non-viral vectors for gene transfer. Contextually, recent advances in molecular...
7.
Marson D, Dymek M, Geyer J
Neurologist
. 2003 Jun;
7(6):317-26.
PMID: 12803662
Background: Obtaining informed consent to treatment is an important medical-legal and clinical aspect of neurological practice. Review Summary: This review discusses the doctrine of informed consent and its role in...
8.
Harrell L, Marson D, Chatterjee A, Parrish J
Alzheimer Dis Assoc Disord
. 2000 Sep;
14(3):168-75.
PMID: 10994658
The bedside and office assessment of cognitive abilities in moderately to severely impaired patients with Alzheimer disease could be enhanced by a well-standardized instrument. The authors' group has developed such...
9.
Kawas C, Clark C, Farlow M, Knopman D, Marson D, Morris J, et al.
Alzheimer Dis Assoc Disord
. 1999 Sep;
13(3):124-9.
PMID: 10485569
During the past 10 years, there has been a rapidly growing number of pharmaceutical industry-sponsored drug trials for treatment of Alzheimer disease (AD) and other neurodegenerative diseases. As public awareness...
10.
Marson D, Harrell L
Semin Clin Neuropsychiatry
. 1999 May;
4(1):41-9.
PMID: 10229792
Loss of medical decision making capacity (competency) is an inevitable consequence of Alzheimer's disease (AD) and is an important subject for neuropsychological investigation. Consent capacity involves a complex set of...